Cited by 601Cardiac Fibrosis and RemodelingCongenital heart defects researchLiver physiology and pathology

The origin of fibroblasts and mechanism of cardiac fibrosis

Open access
Krenning, Guido, Zeisberg, Elisabeth M., Kalluri, Raghu·2010·Journal of Cellular Physiology

Abstract

Fibroblasts are at the heart of cardiac function and are the principal determinants of cardiac fibrosis. Nevertheless, cardiac fibroblasts remain poorly characterized in molecular terms. Evidence is evolving that the cardiac fibroblast is a highly heterogenic cell population, and that such heterogeneity is caused by the distinct origins of fibroblasts in the heart. Cardiac fibroblasts can derive either from resident fibroblasts, from endothelial cells via an endothelial–mesenchynmal transition or from bone marrow‐derived circulating progenitor cells, monocytes and fibrocytes. Here, we review the function and origin of fibroblasts in cardiac fibrosis.NB. The information given is correct. J. Cell. Physiol. 225: 631–637, 2010. © 2010 Wiley‐Liss, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcp.22322

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cardiac fibrosis is characterized by cardiac fibroblast over-proliferation, myofibroblast activation, and increased deposition of fibrous extracellular matrix proteins.

    “Cardiac fibrosis is the scarring process that is characterized by cardiac fibroblast (CF) over-proliferation, myoFB activation, and increased deposition of fibrous ECM proteins [56].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Krenning, G., Zeisberg, E. M., & Kalluri, R.
Affiliations
Beth Israel Deaconess Medical Center (US)
Corresponding author
Kalluri, Raghu
Venue
Journal of Cellular Physiology
Publisher
Wiley
Published
2010-12
Volume
225
Issue
3
Pages
631-637
ISSN
  • 0021-9541 (ISSN-L)
  • 1097-4652
OpenAlex
W2104483699
Cited by
601
References
105
Citations by year
2026: 18 · 2025: 18 · 2024: 19 · 2023: 33 · 2022: 31 · 2021: 47 · 2020: 56 · 2019: 43 · 2018: 39 · 2017: 58 · 2016: 56 · 2015: 42 · 2014: 38 · 2013: 36 · 2012: 45
FWCI
5.48
Type
journal article
Language
en
Open access
Locations
  • Journal of Cellular Physiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Funders
  • National Science Foundation
  • American Heart Association
  • National Cancer Institute (K08CA129204, CA 125550, R01CA125550)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-55001, R01DK055001)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
cardiac fibroblasts, myocardial fibrosis, fibroblast origin, fibroblast heterogeneity, endothelial-to-mesenchymal transition, bone marrow progenitor cells, monocytes, fibrocytes
MeSH terms
Animals, Coronary Vessels, Extracellular Matrix, Fibroblasts, Fibrosis, Heart Diseases, Humans, Morphogenesis, Myocardial Contraction, Myocardium, Phenotype, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Cell Lineage, Endothelial Cells, Cell Transdifferentiation, Excitation Contraction Coupling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review